XML 154 R51.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT REPORTING (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 1  
Interest income $ (5,042) $ (5,945)
Consolidated net loss 69,628 75,521
Life Science    
Segment Reporting Information [Line Items]    
AV-101 clinical trials 19,740 26,548
Employee costs 19,512 21,244
Professional fees and services 11,482 6,289
Stock-based compensation 11,311 11,907
Chemistry, manufacturing, and controls 11,110 14,339
Other segment items 1,515 1,139
Interest income $ (5,042) $ (5,945)